“I don’t see any purpose, but I think they are not independent of each other,” Rambaut said. “Because once this idea is caught, people will go through its stored samples and see what they can find.”
Similar errors have been reported in other studies in Italy before the virus was detected. A study The SARS-Cove-2 RNA was reportedly detected in sewer samples taken in Milan and Turin on December 1, 2011, published in August 2020 by the Department of Environment and Health in Rome. These findings raise suspicions of Johns Hopkins University postdock Alex Krits-Christoph, who specializes in bioinformatics studies of genetic data. The researchers conducted three different experiments, but only one came back positive. They also made their own primers, which were used to target specific regions of the RNA, although standard SARS-Cove-2 primers were used around the world at the time. “It strikes me as a bit weird,” he says.
October 2, 2020, a Study Was submitted to the journal Tumor And the next day was adopted, “which is a very short time, very early peer review – not even a peer review,” says Warobe. The researchers looked at the antibodies of volunteers enrolled in a lung cancer screening trial, recruited from all over the Italian region, and found that hundreds of participants made coronavirus antibodies by September 2019. The first official Covid-1 cases in Lombardy were reported in Italy before the diagnosis, and even long before the first official report from the Chinese authorities, Covid-1 shed new light on the onset and spread of the pandemic epidemic, “the authors wrote. Theoretical Inside Interview So that they can detect a “less contagious” strain that can spread without spreading a large outbreak. The paper was extensive Covered By English speaking Media. But others have pointed out major flaws in the paper. Researchers have not taken the necessary steps to prevent the detection of other coronavirus antibodies, such as the common cold. “Any antibody test has a false positivity, so when you screen a group of people in a very rare situation, most of the positives are going to be false,” said Marion Kupmans, a virologist at Erasmus Medical Center. There were studies Has been declared under investigation By the journal in March 2021, but no corrections were made. The WHO requested that the samples be re-tested in other labs. The Investigation Found that No samples There are sufficient amounts of antibodies that are considered evidence of infection.
Another Study A 25-year-old woman living in Milan saw a skin biopsy on Nov. 10, when she arrived at the hospital with a rash. A few months after a closer look, Raphael Gianotti, the chief researcher and dermatologist who treated her, found evidence of the stork-covi-2 molecule in her skin sample. The WHO wanted to investigate the case, but now No one can find the female patient, And Giannoti died in March. (The rest of the authors in the paper say there is no update on the case.)
Rambaut said the results were “used by different parties to support a particular episode.” In particular, they have been Covered Frequently By China’s state media, turning to research, says China was not the country of origin of the virus. “Uhan was where the coronavirus was first detected, but it did not originate where it was.” Said Zheng Guang, chief epidemiologist at China’s former Centers for Disease Control and Prevention, at an academic conference in November 2020.